uniQure (QURE) Research & Development (2016 - 2026)
uniQure (QURE) recorded quarterly Research & Development of $29.2 million in Q1 2026, down 16.12% quarter-over-quarter from $34.8 million in Q4 2025, and down 19.27% on a YoY basis from $36.1 million in Q1 2025.
uniQure (QURE) Research & Development (2016 - 2026) Analysis & Trends
uniQure's Research & Development history runs 11 years deep, the most recent figure standing at $29.2 million for Q1 2026.
- In Q1 2026, Research & Development fell 19.27% year-over-year to $29.2 million; the TTM figure through Mar 2026 stood at $133.7 million (down 3.97% YoY), while the FY2025 annual figure was $140.7 million, down 2.16% from the prior year.
- Research & Development was $29.2 million for Q1 2026 at uniQure, down from $34.8 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $65.4 million in Q3 2023 to a low of $29.2 million in Q1 2026.
- Historically, Research & Development has averaged $42.7 million across 5 years, with a median of $40.7 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Research & Development soared 41.06% in 2022, then tumbled 53.22% in 2024.
- A 5-year view of Research & Development shows it stood at $58.3 million in 2022, then fell by 26.93% to $42.6 million in 2023, then decreased by 8.87% to $38.8 million in 2024, then decreased by 10.44% to $34.8 million in 2025, then dropped by 16.12% to $29.2 million in 2026.
- The last three Research & Development figures came in at $29.2 million (Q1 2026), $34.8 million (Q4 2025), and $34.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -2.30 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 1.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -58.00 Mn |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn | 29.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.18 Mn |
| Dec 31, 2025 | 34.78 Mn |
| Sep 30, 2025 | 34.37 Mn |
| Jun 30, 2025 | 35.38 Mn |
| Mar 31, 2025 | 36.14 Mn |
| Dec 31, 2024 | 38.84 Mn |
| Sep 30, 2024 | 30.60 Mn |
| Jun 30, 2024 | 33.66 Mn |
| Mar 31, 2024 | 40.69 Mn |
| Dec 31, 2023 | 42.62 Mn |
| Sep 30, 2023 | 65.40 Mn |
| Jun 30, 2023 | 46.04 Mn |
| Mar 31, 2023 | 60.81 Mn |
| Dec 31, 2022 | 58.33 Mn |
| Sep 30, 2022 | 48.07 Mn |
| Jun 30, 2022 | 46.19 Mn |
| Mar 31, 2022 | 45.00 Mn |
| Dec 31, 2021 | 42.34 Mn |
| Sep 30, 2021 | 36.43 Mn |
| Jun 30, 2021 | 32.75 Mn |